i 杜仲 · iDuZhong杜仲名人堂 · HALL OF FAME 全部人物All
王

王好古

Wang Haogu

金元医学家、易水学派传人
Jin–Yuan physician; inheritor of the Yishui school
源流·典籍
Classics
“杜仲古方只知滋肾,惟王好古言是肝经气分药,润肝燥,补肝虚,发昔人所未发也。——李时珍《本草纲目》杜仲条发明”

人物简介

首倡杜仲'肝经气分药,润肝燥补肝虚',发前人所未发。

事迹

王好古(约1200—1264),字进之,号海藏,赵州人,金元之际著名医学家。他承张元素、李杲之学,著《汤液本草》三卷,以升降浮沉、归经学说阐发药性,是金元药理学的代表作。

在杜仲条中,他突破古方'只知滋肾'的传统,明确提出杜仲为'肝经气分药',能'润肝燥,补肝经风虚'。李时珍在《本草纲目》杜仲'发明'项中盛赞其'发昔人所未发',并引申出'肝主筋,肾主骨……杜仲色紫而润,甘温能补,微辛能润,故能入肝而补肾'的经典论述。杜仲'补肝肾、强筋骨'的现代法定功效,理论源头即在王好古此说。

重要活动 / 事件

  • 师从李杲、张元素,为易水学派第三代传人
  • 历任赵州教授、医学教授,著《汤液本草》《阴证略例》等
  • 以归经学说系统整理常用药物,杜仲为其归经理论典型药例之一

代表贡献

  • 《汤液本草》创药性归经理论体系,杜仲条载'味辛甘平温,无毒。阳也,降也'
  • 首创杜仲入肝经之说:'(杜仲)肝经气分药也','润肝燥,补肝经风虚'
  • 其说被李时珍高度评价:'杜仲古方只知滋肾,惟王好古言是肝经气分药……发昔人所未发也'
  • 将杜仲功效从单纯补肾拓展为肝肾同治,奠定'肝主筋、肾主骨'用药理论
“Ancient formulas knew Duzhong only as a kidney tonic; only Wang Haogu said it is a qi-aspect drug of the Liver channel, moistening liver dryness and tonifying liver deficiency—he brought forth what earlier men had not. — Li Shizhen, Compendium of Materia Medica, 'Faming' on Eucommia”

Profile

First proposed that Eucommia is 'a qi-aspect drug of the Liver channel, moistening liver dryness and tonifying liver deficiency'—an insight his predecessors had not reached.

Story

Wang Haogu (c. 1200–1264), courtesy name Jinzhi, hao Haizang, of Zhaozhou, was a famous physician of the Jin–Yuan era. Inheriting the learning of Zhang Yuansu and Li Gao, he wrote the three-juan Tangye Bencao, expounding drug properties through the theories of ascending-descending-floating-sinking and channel tropism—a representative work of Jin–Yuan pharmacology.

In the Eucommia entry he broke with the ancient-formula tradition of 'knowing only kidney tonification', explicitly proposing that Eucommia is 'a qi-aspect drug of the Liver channel' able to 'moisten liver dryness and tonify wind-deficiency of the Liver channel'. In the 'Faming' (elucidation) section of the Compendium of Materia Medica's Eucommia entry, Li Shizhen praised him for 'bringing forth what earlier men had not', deriving the classic dictum: 'the liver governs sinews, the kidney governs bones... Duzhong is purple and moist; sweet-warm it can tonify, slightly pungent it can moisten, thus it enters the liver and tonifies the kidney.' The theoretical source of Eucommia's modern official action—'tonifying liver and kidney, strengthening sinews and bones'—lies precisely in Wang Haogu's insight.

Milestones

  • Studied under Li Gao and Zhang Yuansu, becoming a third-generation inheritor of the Yishui school
  • Served as instructor of Zhaozhou and professor of medicine; authored Tangye Bencao, Yinzheng Lueli, and other works
  • Systematically organized commonly used drugs by channel-tropism theory; Eucommia is one of the typical examples of his theory

Key Contributions

  • His Tangye Bencao (Materia Medica for Decoctions) established the channel-tropism theory of drug properties; its Eucommia entry reads 'pungent, sweet, neutral to warm, non-toxic. It is yang; it descends'
  • First proposed that Eucommia enters the Liver channel: '(Duzhong) is a qi-aspect drug of the Liver channel', 'moistening liver dryness and tonifying wind-deficiency of the Liver channel'
  • His view was highly praised by Li Shizhen: 'Ancient formulas knew Duzhong only as a kidney tonic; only Wang Haogu said it is a qi-aspect drug of the Liver channel... he brought forth what earlier men had not'
  • Expanded Eucommia's action from merely tonifying the kidney to treating liver and kidney together, laying the theoretical basis of 'the liver governs sinews, the kidney governs bones'
QR · 王好古
长按识别二维码 · 访问「杜仲名人堂」Scan to open the Eucommia Hall of Fame
i 杜仲 · 杜仲全产业链大数据平台i DuZhong · Eucommia Full-Chain Data Platform
iduzhong.factorydossier.com
查看全部人物All figures 微信点右上角 ··· 转发;或长按二维码识别访问In WeChat tap ··· to share; long-press the QR to open
← 唐慎微← Tang Shenwei 进入 i 杜仲全产业链数据平台 →Enter the i DuZhong platform → 陈嘉谟 →Chen Jiamo →
i 杜仲 · 杜仲全产业链大数据平台 · 杜仲名人堂
人物事迹依据公开权威资料整理;补录人物或提供照片:[email protected]
i DuZhong · Eucommia Full-Chain Big Data Platform · Hall of Fame
Profiles compiled from public sources. To contribute: [email protected]